CD7 CAR-T in Adults With Relapsed or Refractory T-LBL/ALL Clinical Study
Clinical trial NCT06136364 · RECRUITING
Trial details
- NCT number
- NCT06136364
- Sponsor
- Hebei Senlang Biotechnology Inc., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2024-08-15
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.